Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Indexes aggregate market data to track performance, provide benchmarks, and simplify investment decisions for portfolios and strategies.
24,038 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Ford faced headwinds in its EV push, but a bold pivot could unlock durable value. Explore the battery storage strateg...
Is GameStop stock a buy, hold, or sell in today’s market? This practical guide walks you through the current dynamics...
A mid-June rally lifted AMC Entertainment after it completed a $150 million equity offering. The move boosted sentime...
When the crowd sells Coca-Cola, you might wonder if the stock is doomed. This article explains why a dip can reveal v...
June brought a tech-focused pullback as Apple raised device prices to offset memory costs. This deep dive explains wh...
Celebrity pet buys spark debate about money, ethics, and budgeting. This guide translates that moment into practical ...
As AI reshapes energy, manufacturing, and city grids, one infrastructure stock quietly stands out. Learn why this cri...
When a top investor adds to a position after a selloff, it can reveal confidence not just in a single company, but in...
SpaceX finally faces the public market with its first earnings call after the IPO. This guide breaks down what invest...
A large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...